Stem Cell Therapy Market (By Product: Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells; By Therapy Type; By Application; By Technology; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global stem cell therapy market size was valued at USD 9.87 billion in 2021 and is expected to hit around USD 31.41 billion by 2030 and is poised to grow at a compound annual growth rate (CAGR) of 13.73% during the forecast period 2022 to 2030.

Stem Cell Therapy Market Size 2022 To 2030

Key Takeaways:

  • By product, the adult stem cells (ASCs) segment has reached 85.9% revenue share in 2021
  • The induced pluripotent stem cells (iPSCs) segment is predicted to grow at a CAGR of 9.5% between 2022 to 2030
  • By application, the regenerative medicine segment has garnered 91% in 2021
  • The drug discovery and development application segment is projected to grow at a CAGR of 9.5% from 2022 to 2030
  • By therapy, allogenic stem cell therapy has hit market share of 58.5% in 2021
  • North America accounted for the largest market share of 53% in 2021
  • Asia Pacific is expected to grow at a CAGR of 9.2% between 2022 to 2030

There has been a constant growth in the research associated with the stem cell activities and the number of approval start come from the authorities have increased due to which the market for the stem cell therapy has grown well in the past and it is expected to grow during the forecast period. Due to constant research and development activities in the stem cell treatment market there has been a growth in the demand for the gene treatments and the cell treatments with the help of the stem cells. There has been an increased number of clinical trials that have been registered and they may affect the demand of this market to a great extent and lead to an increased sale.

In the developed nations and other nations that have a good spending power the demand for various medicines of the innovative nature is expected to grow well in the coming years as they may be helpful in treating different types of disorders like the cardiovascular disorders, neurological disorders and the autoimmune disorders. The stem cell treatment or therapy market is expected to grow due to an increase in the number of all of these diseases across the globe. There has also been an increased funding that has led to the growth of the market in the past. There is potential life in the human embryo and destroying the embryo is not ethical even though it is used in the treatment and it may be helpful in saving the lives.

During the outbreak of the pandemic which affected the global economy at large discovered 19 pandemic header good impact on the stem cell treatment market. For treating the virus, the stem cells have been used for various clinical trials. Due to the use of the regenerative medicines a better treatment can be offered for the patients that will help in reducing the cases to a great extent. It may also be helpful in reducing the rate of infection among the people. In the coming years the demand for this product is expected to grow as many clinical trials or getting clearance from the authorities. As there has been an increase in the number of various chronic diseases across the globe the demand for stem cell therapy is expected to grow and these increasing number of diseases will provide opportunities for the growth of the market in the coming years.

Constant research and development activities have provided novel therapies. iPSC’s Are used on a large scale by different research scientists across the globe for conducting studies against cancer. This product has been used in the clinical trials against the Parkinson's disease, Alzheimer's disease etc. increase in the number of these trials were led to the growth of the market in the coming years. During the pandemic the researchers were concentrating on providing treatment for combating the COVID-19 virus. The use of the stem cells for treating COVID-19 has been effective. In order to improve the research activities associated with the stem cell market Australian government has invested and provided a road map for the upcoming 10 years.

Report Scope of the Stem Cell Therapy Market

Report Coverage Details
Market Size in 2022

USD 11.22 Billion

Market Size by 2030

USD 31.41 Billion

Growth Rate from 2022 to 2030 CAGR of 13.73%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Therapy Type, Application, Technology, End User, Geography
Companies Mentioned

Caladrius, CELGENE CORPORATION, ReNeuron Group plc, Virgin Health Bank, Opexa Therapeutics, Inc., Pluristem Therapeutics Inc, STEMCELL Technologies Inc., Biovault family, Precious Cells International, Ltd, Mesoblast Ltd,  Seneca Biopharmaceuticals, Inc.


Growth Factors

In the year 2021 it was seen that the chronic diseases had increased by about 58% and this data was provided by the World Health Organization. As the developing nations are highly populated, they have the maximum number of chronic diseases and the demand for the treatment of these diseases is expected to grow in this region. The cases of the Alzheimer's disease have increased to a great extent in the North American region especially in the United States. the number of patients that may suffer with Alzheimer's by the year 2030 its projected to be 8.4 million. This is yet another reason why the market is expected to grow due to an increased rate of the people suffering with various chronic diseases.

Constant awareness regarding the availability of the therapies that make use of stem cells have led to an increased demand for the innovation and development of the system. Most of the market players are concentrating on forming collaborations in order to improve their research and development activities which may be helpful in increasing the market for the stem cell treatment across the developing as well as the developed nations in the coming years. There has been an increased amount of funding which has been invested further research that is cell based. There is a growing demand for the induced pluripotent stem cells which involves the genetic reprogramming of the stem cells of the adult human body in order to gather the stem cells of the embryonic stage. It happens to be a great alternative for the embryonic stem cells in the market.

Return increase number of funding which comes from the private as well as the public organizations there shall be an increase in the number of products used for the treatment of various diseases. The market is expected to grow maximum in the North American region and there shall be an increased sales or they shall be an increased demand for this therapy in the North American region during the forecast period. Followed by the North American region the Asia Pacific and the European region is also expected to have a good demand for the stem cell treatment during the forecast period.

Type Insights

Depending upon the type, the allogeneic stem cell therapy segment accounted for about 58.5% in the 2021. As the allergenic stem cell segment has seen a growing demand in the past which is due to the usage in treatment against cancer and the growing number of cases of this dreadful disease will create a greater demand in the coming years. With the help of the immune system cells the cancerous cells can be killed and these cells can be acquired from a donor. The segment is expected to grow well in the coming years due to its increased application for treating different types of cancers like leukemia lymphoma and myeloma.

Apart from the growing demand for to allogeneic segment the autologous segment is also expected to grow well in the coming years the autologous therapy segment is expected to grow at a higher compound annual growth rate in the coming years. As the use of this therapy reduces the chances of complications the market is expected to grow well. Also, the use of this therapy is expected to grow well in the coming years due to the lower chances of the rejection of the graft. The use of this treatment has largely affected the market as the survival rates have increased. This segment is expected to grow well in the coming years as it is affordable as compared to the other type. This happens to be a low-risk alternative.

Application Insights

Depending upon the basis of application, the region relative medicine segment is expected to have the largest share in the market in the coming years. The segment has dominated the market in the past with a share of about 91% and it is expected to grow well in the coming years. The demand for regenerative medicine especially for the neurological disorders is expected to grow in the coming years as that has been an increased number of approvals that are associated with the clinical trials for treating different types of diseases. Governments of various nations are increasing their investments for developing the regenerative medicines. These medicines will be helpful in treating different chronic disorders, diabetes, heart disease and blood disorder.

Stem Cell Therapy Market Share, By Application, 2021 (%)

Apart from the growing demand of the stem cell therapy or the stem cells market for various regenerative medicines they shall be good demand for the development and the discovery of the drugs.

End User Insights

On the basis of the end user, the hospital segment is expected to have a dominant position in the coming years. The way level infrastructure and the different types of treatment options will help in the growth of the market in the coming years. As the hospitals have been instrumental in providing good treatment to the patience due to their association with the various research institutes which help them in coming up with novel therapies against various diseases these collaborations have being extremely favorable for the growth of the market in the past and they shall be instrumental in developing the market in the future.

Stem Cell Therapy Market Share, By Region, 2021 (%)

Regions Revenue Share in 2021 (%)
North America 53%
Asia Pacific 15%
Europe 21%
Latin America 6%
MEA 5%


Regional Insights

The North American region has dominated the market in the past and it is expected to have a dominant position even in the coming years. This region had a share of about 53% in the past as major manufacturing units are present in the North American region. The availability of the research and development units and advanced infrastructure in the healthcare segment shall be instrumental in the growth of the market. Constant reforms in this nation that are supportive for the healthcare sector and the presence of favorable reimbursement policies will play a great role in the growth of the market. Initiatives taken by the government in the United States are highly favorable for the research activities.

Constant promotion and awareness regarding the use of this therapies for various diseases through these organizations will be instrumental in increasing the demand for the treatment. The Asia Pacific region is also expected to grow well in the coming years and it is expected to grow at the highest compound annual growth rate of about 9.2% in the coming years. Favorable initiatives from the government and increased research activities will be helpful in the development of the stem cell treatments market in the Asia Pacific region.

Key market developments

  • For the use of the cultured cells and to maintain the health of these cells especially for their use in the transplants of the stem cells for various patients a new method was developed by understanding the causative factor by the scientists from the University of California in the year 2021.

Key market players

  • Caladrius
  • CELGENE CORPORATION
  • ReNeuron Group plc
  • Virgin Health Bank
  • Opexa Therapeutics, Inc.
  • Pluristem Therapeutics Inc
  • STEMCELL Technologies Inc.
  • Biovault family
  • Precious Cells International Ltd
  • Mesoblast Ltd
  • Seneca Biopharmaceuticals, Inc.

Segments covered in the report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Adult Stem Cells (ASCs)
    • Hematopoietic
    • Mesenchymal
    • Neural
    • Epithelial/Skin
    • Others
  • Human Embryonic Stem Cells (HESCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Very Small Embryonic Like Stem Cells

By Therapy Type

  • Autologous
  • Allergenic

By Application

  • Regenerative Medicine
    • Neurology
    • Orthopedics
    • Oncology
    • Hematology
    • Cardiovascular and Myocardial Infraction
    • Injuries
    • Diabetes
    • Liver Disorder
    • Incontinence
    • Others
  • Drug Discovery and Development

By Technology

  • Cell Acquiition
    • Bone Marrow Harvest
    • Umbilical Blood Cord
    • Apheresis
  • Cell Production
    • Therapeutic Cloning
    • In-vitro Fertilization
    • Cell Culture
    • Isolation
  • Cryopreservation
  • Expansion and Sub-Culture

By End User

  • Hospitals
  • Research institutes
  • surgical institutes
  • Orders

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of stem cell therapy market?
The global stem cell therapy market size was accounted at USD 9.87 billion in 2021 and it is expected to reach around USD 31.41 billion by 2030.
The global stem cell therapy market is poised to grow at a CAGR of 13.73% from 2022 to 2030.
The major players operating in the stem cell therapy market are CELGENE CORPORATION, ReNeuron Group plc, Virgin Health Bank, Opexa Therapeutics, Inc., Pluristem Therapeutics Inc, STEMCELL Technologies Inc., Biovault family, Precious Cells International, Ltd, Mesoblast Ltd, Caladrius, Seneca Biopharmaceuticals, Inc.
In order to improve the market for the stem cell therapies a 10-year road map for the research activities associated with the stem cell was provided by the Australian government. Many major steps taken by various governments in a similar fashion will drive the market growth in the coming years period
North America region will lead the global stem cell therapy market during the forecast period 2022 to 2030.
  • Report Code:1989
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample